State of Wyoming’s Viking Therapeutics VKTX Stock Holding History

State of Wyoming’s Portfolio VKTX Stock Details VKTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-31	Closed	–	–	1342
2021 Q2	$0	Buy	+31	New	+$184	﹤0.01%	1224

Other funds holding VKTX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

State of Wyoming's VKTX Position: Q3 2021 in Review

State of Wyoming sold out of Viking Therapeutics (VKTX) in Q3 2021, closing a stake of 31 shares.

State of Wyoming first reported a position in VKTX in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 134 funds tracked by Wall St. Rank hold VKTX as of Q3 2021.

State of Wyoming reported no remaining Viking Therapeutics position as of Q3 2021 after selling out during the quarter.
State of Wyoming sold 31 Viking Therapeutics shares in Q3 2021.
State of Wyoming first reported a position in Viking Therapeutics in Q2 2021 and held it in 1 quarter.
State of Wyoming's Viking Therapeutics position peaked at $0 in Q2 2021.
134 funds tracked by Wall St. Rank held Viking Therapeutics as of Q3 2021.

Based on State of Wyoming's 13F filing for Q3 2021, filed 11 Feb 2022.